Self managed exercise improves walking
- Trial ID
- NCT07302386
- Official Title
- The Effects of Exercise Management in Parkinson's Disease
- Goal
- Self managed exercise improves walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Marmara University
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease (PD)
- Interventions
- Telerehabilitation
Plain-Language Summary
The trial aims to see whether a structured exercise program delivered remotely can improve walking, balance, and everyday mobility for people with mild-to-moderate Parkinson's. Participants do telerehabilitation sessions guided by therapists over video or an app, using targeted strength, balance, and movement exercises that help muscle function and motor control and support brain plasticity; this approach is meant to complement medications like levodopa, not replace them. They are enrolling people age 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stage I to III, MoCA 21 or higher, able to walk 100 meters and use basic technology, and not on deep brain stimulation or living with other major neurologic, cardiopulmonary, musculoskeletal, vision, or hearing problems.
Locations
- Marmara University, Maltepe, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Telerehabilitation. The trial aims to see whether a structured exercise program delivered remotely can improve walking, balance, and everyday mobility for people with mild-to-moderate Parkinson's. Participants do telerehabilitation sessions guided by therapists over video or an app, using targeted strength, balance, and movement exercises that help muscle function and motor control and support brain plasticity; this approach is meant to complement medications like levodopa, not replace them. They are enrolling people age 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stage I to III, MoCA 21 or higher, able to walk 100 meters and use basic technology, and not on deep brain stimulation or living with other major neurologic, cardiopulmonary, musculoskeletal, vision, or hearing problems.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 11 months.